Cancer, Cytologism and the Kinase Inhibitors Saga
Organisms. Journal of Biological Sciences · 23.07.2024
DOI: 10.13133/2532-5876/18136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organisms. Journal of Biological Sciences, erschienen am 23.07.2024. Verfasst von Carlos Sonnenschein und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The role of kinases in the cell cycle of unicellular eukaryotes and cells of multicellular organisms has been the object of numerous studies involving normal and cancer cells. These studies described in detail how two daughter cells are generated from a single normal or cancer mother cell. Among the thousands of participants in the cell cycle, kinases play a crucial role in the dynamic aspects of the cell cycle thanks to the phosphorylation of substrates with which they react. Inhibitors of these kinases have figured prominently among the strategies to treat cancers. However, evidence shows that the benefits that cancer patients accrued from this therapeutic approach have been of a limited degree. In this article, we review the rationale for adopting such a strategy and the factors that contribute to its shortcomings.
Schlagwörter
Zitieren
APA
Sonnenschein, C., & Páldi, A. (2024). Cancer, Cytologism and the Kinase Inhibitors Saga. Organisms. Journal of Biological Sciences. https://doi.org/10.13133/2532-5876/18136
Vancouver
Sonnenschein C, Páldi A. Cancer, Cytologism and the Kinase Inhibitors Saga. Organisms. Journal of Biological Sciences. 2024. doi:10.13133/2532-5876/18136
BibTeX
@article{Sonnenschein2024,
author = {Sonnenschein, Carlos and Páldi, Andràs},
title = {Cancer, Cytologism and the Kinase Inhibitors Saga},
journal = {Organisms. Journal of Biological Sciences},
year = {2024},
doi = {10.13133/2532-5876/18136}
}
EUVIMED